NCBI PubMed Central
open access
Single-cell multi-omics dissection of RevitalAge Markers uncovers age-dependent immunotherapy resistance and druggable targets in melanoma.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Combination Immunotherapy Targeting Melanoma#417557
- The Multicentre Selective Lymphadenectomy Trial - 3#978871
- Trial of Single Agent Sunitinib for Patients With Chemo-refractory Metastatic Melanoma#969001
- Longitudinal and Multi-Omics Analysis of Metastatic Melanoma Reveals Dynamic Tumor Evolution and Multi-Level Heterogeneity#202406
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma#6758
Record · ID 388769
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive